Search

everythinglearnresearchcommunity

for

Search:↓

New regenerative treatments for hair loss show promise but need more research for confirmation.

Long COVID causes a wide range of long-lasting symptoms that change over time and are hard to diagnose and treat.

The review shows that skin symptoms like chronic fungal infections, hair loss, and skin depigmentation are key for early detection and management of APECED.

Mesenchymal stem cells could help treat radiation-induced bladder damage but more research is needed to overcome current limitations.

Innate lymphoid cells help control skin bacteria by regulating sebaceous glands.

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.

SLE patients with Evans syndrome often show blood issues and need careful monitoring and treatment.

A man developed autoimmune issues after a transplant, improved with treatment, but died from leukemia relapse.

The document concludes that understanding hair follicle histology and the hair cycle is crucial for diagnosing alopecia.

Tigers had a skin condition causing hair loss and inflammation, but the cause is unknown and treatment didn't work.

Foreign-body granuloma may be a marker for late-stage Lichen Planopilaris and should be considered in diagnosis.

A 9-year-old girl with alopecia areata had successful hair regrowth using bimatoprost after other treatments failed.

People with alopecia areata often have lower levels of vitamin D, zinc, and folate, but more research is needed to understand if supplements can help treat it.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

Low serum complement levels in SLE patients don't always match with disease flares; monitoring C3 and C4 is useful, but cell-bound complement products might better indicate disease activity.

Bimatoprost was found to be safer and more effective than mometasone furoate for treating scalp hair loss.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

Topical clobetasol is recommended over mycophenolate mofetil for treating Lichen Planopilaris due to better safety and patient satisfaction.

Some patients receiving pegylated interferon alfa injections developed skin necrosis, requiring treatment adjustments or discontinuation.

Most people with alopecia areata have nail changes, which are common but don't greatly affect their quality of life.

Hydroxychloroquine may help treat alopecia areata in children.

Combining light therapy, acid, and microneedling improves hair regrowth in stubborn hair loss cases.

Simvastatin/ezetimibe did not effectively treat severe alopecia areata and caused side effects in some patients.

Mycophenolate mofetil can effectively treat autoimmune hepatitis when standard drugs fail.

Low vitamin D levels are common in people with Alopecia Areata.

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.

HSP90 and lamin A/C are crucial for hair growth and could be targets for treating hair loss.

Antiandrogenic drugs could be a good treatment option for frontal fibrosing alopecia.

Mitochondrial therapy and platelet-rich plasma therapy both stimulated hair regrowth in aging mice, with mitochondrial therapy showing similar effectiveness to plasma therapy.